The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
Chemical Compound Review

Expert     oxetan-3-yl 2-[(4,6-dimethylpyrimidin-2...

Synonyms: Oxasulfuron, SureCN66884, CGA-277476, LS-195724, EP-A 0496701, ...
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Oxasulfuron

  • Screening guidelines proposed by the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus have been endorsed by several medical societies [1].
  • American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer. American Society of Clinical Oncology Bisphosphonates Expert Panel [2].
  • The American Society of Clinical Oncology (ASCO) Colorectal Cancer Surveillance Expert Panel was guided by the principle of cost minimization, ie, when two strategies were believed to be equally effective, the least expensive test was recommended [3].
  • BACKGROUND: The NHLBI (National Heart, Lung, and Blood Institute) Obesity Education Initiative Expert Panel recently proposed that clinicians and other health care professionals use a new treatment algorithm to identify patients for weight-loss treatment [4].
  • Guidelines for overweight in adolescent preventive services: recommendations from an expert committee. The Expert Committee on Clinical Guidelines for Overweight in Adolescent Preventive Services [5].
 

Psychiatry related information on Oxasulfuron

 

High impact information on Oxasulfuron

  • CONCLUSION: Expert opinion and the opinion of readers as to what JAMA should emphasize vary widely [11].
  • Advice and initial procedures were categorized based on the recommendations of the US Public Health Service Expert Panel on the Content of Prenatal Care. DESIGN--Interview survey of a nationally representative sample of women who had live births in 1988 [12].
  • We used GABRIEL (Genetic Analysis By Rules Incorporating Expert Logic), a platform of knowledge-based algorithms for the global analysis of gene expression, together with conventional statistical approaches, to examine the sensitivity of conclusions to threshold choice in recently published microarray-based studies [13].
  • METHODS: An American Society of Clinical Oncology (ASCO) Expert Panel conducted a systematic review of the literature available through February 2004 on the use of SNB in early-stage breast cancer [14].
  • 2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel [15].
 

Chemical compound and disease context of Oxasulfuron

  • In 1967, a WHO Expert Committee Report on the Control of Ascariasis pointed out that information on the frequency of dust-borne infection with Ascaris in man was inadequate [16].
  • Validation of the VITEK2 and the Advance Expert System with a collection of Enterobacteriaceae harboring extended spectrum or inhibitor resistant beta-lactamases [17].
  • In 2002, the American Headache Society convened the Triptan Cardiovascular Safety Expert Panel to evaluate the evidence on triptan-associated cardiovascular risk and to formulate consensus recommendations for making informed decisions for their use in patients with migraine [18].
  • Glucose tolerance test and glycosylated haemoglobin measurement for diagnosis of diabetes mellitus--an assessment of the criteria of the WHO Expert Committee on Diabetes Mellitus 1980 [19].
  • NTP-CERHR Expert Panel Update on the Reproductive and Developmental Toxicity of di(2-ethylhexyl) phthalate [20].
 

Biological context of Oxasulfuron

  • Immunological research in clinical psychiatry: report on the consensus debate during the 7th Expert Meeting on Psychiatry and Immunology [21].
  • A classification of atrial flutter and regular atrial tachycardia according to electrophysiological mechanisms and anatomical bases; a Statement from a Joint Expert Group from The Working Group of Arrhythmias of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology [22].
  • OBJECTIVE: The goal of this study was to evaluate the efficacy of the Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (ATP III) in identifying insulin resistance [23].
  • This review examines areas of overlap and discordance in practice guidelines issued by the American Psychiatric Association and the British Association for Psychopharmacology, as well as treatment algorithms developed by the Expert Consensus Guideline Series and the Texas Medical Algorithm Project [24].
  • Reassessment of the association between Guillain-Barré syndrome and receipt of swine influenza vaccine in 1976-1977: results of a two-state study. Expert Neurology Group [25].
 

Anatomical context of Oxasulfuron

  • American College of Cardiology/American Heart Association Expert Consensus Document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease [26].
  • BACKGROUND: Pathfinder is an Expert System that assists pathologists in making accurate diagnoses in the domain of lymph-node pathology [27].
  • Although physicians were generally supportive of the intervention, the physicians' use of the Emergency Department Expert Charting System and satisfaction with the modules were greatest with occupational exposure to blood and body fluids and least with fever in children [28].
  • Vaccination against cancer will likely only be effective at preventing growth of micrometastatic disease while adoptive T cell therapy will be better suited for eradication of bulky pre-existing disease (Knutson et al. Expert Opin Biol Ther 2002; 2:55-66) [29].
  • Both 3-D kinematic and kinetic data of the upper extremity were collected synchronously using a Hi-Res Expert Vision motion system and an instrumented wheel during wheelchair propulsion [30].
 

Associations of Oxasulfuron with other chemical compounds

  • A critique of the report of the National Institutes of Health Expert Panel on detection, evaluation, and treatment of high blood cholesterol [31].
  • Integrating complementary medicine into cardiovascular medicine. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (Writing Committee to Develop an Expert Consensus Document on Complementary and Integrative Medicine) [32].
  • The VITEK 2 Advanced Expert System (AES) identified the ESBL phenotype in only 25 isolates (62.5%), and erroneously reported cephalosporin susceptibility in 11 isolates (28%) [33].
  • Recommendations (formerly known as requirements) for meningococcal polysaccharide vaccines were adopted by the World Health Organisation (WHO) Expert Committee on Biological Standardisation in 1976 and amended in 1978 and 1981 [34].
  • Propylhexedrine, a sympathomimetic with varied medicinal uses, is one of the compounds to be reviewed by the Expert Committee convened by the World Health Organization (WHO) to determine whether the compound should be scheduled under the Convention on Psychotropic Substances [35].
 

Gene context of Oxasulfuron

  • Subsequently the Expert Committee on Biological Standardization of the World Health Organization (ECBS-WHO) meeting in Geneva, Switzerland in October 1995 approved plasma PAI-1 (92/654) as the International Standard [36].
  • It is planned to present the results of this study to the Expert Committee on Biological Standardization of the World Health Organization at its next meeting and to request that the preparation to t-PA, coded 86/670, be established as the 2nd International Standard for t-PA [37].
  • On the basis of the results reported here and with the authorization of the Expert Committee on Biological Standardization of the World Health Organization (WHO) this preparation (coded 92/680) was established as the first international standard of SAA [38].
  • The World Health Organization (WHO) has also come to recognise its importance after SARS and organised the first Expert Consultation on Outbreak Communications conference in Singapore in September 2004 [39].
  • The Expert Panel concluded that combination therapy with leflunomide has a place in the treatment of RA [40].
 

Analytical, diagnostic and therapeutic context of Oxasulfuron

  • CONCLUSION: In this study, good perinatal outcomes and patient satisfaction were maintained when the prenatal visit schedule proposed by the Expert Panel on the Content of Prenatal Care was observed [41].
  • ACC Expert Consensus document on coronary artery stents. Document of the American College of Cardiology [42].
  • OBJECTIVES: Expert panels have developed several guidelines for initiating highly active antiretroviral therapy (HAART) in patients with HIV infection [43].
  • American College of Cardiology/Society for Cardiac Angiography and Interventions Clinical Expert Consensus Document on cardiac catheterization laboratory standards. A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents [44].
  • The National Asthma Education and Prevention Program (NAEPP) Expert Panel II recommended a stepped care pharmacotherapy approach to asthma treatment based on an objective assessment of asthma severity using daytime symptoms, nocturnal symptoms, and physiologic lung function [45].

References

  1. Effectiveness of diabetes mellitus screening recommendations. Dallo, F.J., Weller, S.C. Proc. Natl. Acad. Sci. U.S.A. (2003) [Pubmed]
  2. American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer. American Society of Clinical Oncology Bisphosphonates Expert Panel. Hillner, B.E., Ingle, J.N., Berenson, J.R., Janjan, N.A., Albain, K.S., Lipton, A., Yee, G., Biermann, J.S., Chlebowski, R.T., Pfister, D.G. J. Clin. Oncol. (2000) [Pubmed]
  3. Recommended colorectal cancer surveillance guidelines by the American Society of Clinical Oncology. Desch, C.E., Benson, A.B., Smith, T.J., Flynn, P.J., Krause, C., Loprinzi, C.L., Minsky, B.D., Petrelli, N.J., Pfister, D.G., Somerfield, M.R. J. Clin. Oncol. (1999) [Pubmed]
  4. Identifying patients for weight-loss treatment: an empirical evaluation of the NHLBI obesity education initiative expert panel treatment recommendations. Kiernan, M., Winkleby, M.A. Arch. Intern. Med. (2000) [Pubmed]
  5. Guidelines for overweight in adolescent preventive services: recommendations from an expert committee. The Expert Committee on Clinical Guidelines for Overweight in Adolescent Preventive Services. Himes, J.H., Dietz, W.H. Am. J. Clin. Nutr. (1994) [Pubmed]
  6. Validity of controlled cinical trials of psychotherapy: findings from the NIMH Treatment of Depression Collaborative Research Program. Ablon, J.S., Jones, E.E. The American journal of psychiatry. (2002) [Pubmed]
  7. The Expert Consensus Guidelines for treating depression in bipolar disorder. Frances, A.J., Kahn, D.A., Carpenter, D., Docherty, J.P., Donovan, S.L. The Journal of clinical psychiatry. (1998) [Pubmed]
  8. International Study of Expert Judgement on Therapeutic Use of Benzodiazepines and Other Psychotherapeutic Medications: V. Treatment strategies in panic disorder, 1992-1997. Uhlenhuth, E.H., Balter, M.B., Ban, T.A., Yang, K. Journal of clinical psychopharmacology. (1998) [Pubmed]
  9. The Texas Children's Medication Algorithm Project: Report of the Texas Consensus Conference Panel on Medication Treatment of Childhood Attention-Deficit/Hyperactivity Disorder. Part I. Attention-Deficit/Hyperactivity Disorder. Pliszka, S.R., Greenhill, L.L., Crismon, M.L., Sedillo, A., Carlson, C., Conners, C.K., McCracken, J.T., Swanson, J.M., Hughes, C.W., Llana, M.E., Lopez, M., Toprac, M.G. Journal of the American Academy of Child and Adolescent Psychiatry. (2000) [Pubmed]
  10. The Texas Children's Medication Algorithm Project: Report of the Texas Consensus Conference Panel on Medication Treatment of Childhood Attention-Deficit/Hyperactivity Disorder. Part II: Tactics. Attention-Deficit/Hyperactivity Disorder. Pliszka, S.R., Greenhill, L.L., Crismon, M.L., Sedillo, A., Carlson, C., Conners, C.K., McCracken, J.T., Swanson, J.M., Hughes, C.W., Llana, M.E., Lopez, M., Toprac, M.G. Journal of the American Academy of Child and Adolescent Psychiatry. (2000) [Pubmed]
  11. A comparison of the opinions of experts and readers as to what topics a general medical journal (JAMA) should address. Lundberg, G.D., Paul, M.C., Fritz, H. JAMA (1998) [Pubmed]
  12. Relation of the content of prenatal care to the risk of low birth weight. Maternal reports of health behavior advice and initial prenatal care procedures. Kogan, M.D., Alexander, G.R., Kotelchuck, M., Nagey, D.A. JAMA (1994) [Pubmed]
  13. Effects of threshold choice on biological conclusions reached during analysis of gene expression by DNA microarrays. Pan, K.H., Lih, C.J., Cohen, S.N. Proc. Natl. Acad. Sci. U.S.A. (2005) [Pubmed]
  14. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. Lyman, G.H., Giuliano, A.E., Somerfield, M.R., Benson, A.B., Bodurka, D.C., Burstein, H.J., Cochran, A.J., Cody, H.S., Edge, S.B., Galper, S., Hayman, J.A., Kim, T.Y., Perkins, C.L., Podoloff, D.A., Sivasubramaniam, V.H., Turner, R.R., Wahl, R., Weaver, D.L., Wolff, A.C., Winer, E.P. J. Clin. Oncol. (2005) [Pubmed]
  15. 2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel. Ozer, H., Armitage, J.O., Bennett, C.L., Crawford, J., Demetri, G.D., Pizzo, P.A., Schiffer, C.A., Smith, T.J., Somlo, G., Wade, J.C., Wade, J.L., Winn, R.J., Wozniak, A.J., Somerfield, M.R. J. Clin. Oncol. (2000) [Pubmed]
  16. Aspects of intestinal parasitism in villagers from rural peninsular India. Bidinger, P.D., Crompton, D.W., Arnold, S. Parasitology (1981) [Pubmed]
  17. Validation of the VITEK2 and the Advance Expert System with a collection of Enterobacteriaceae harboring extended spectrum or inhibitor resistant beta-lactamases. Cantón, R., Pérez-Vázquez, M., Oliver, A., Coque, T.M., Loza, E., Ponz, F., Baquero, F. Diagn. Microbiol. Infect. Dis. (2001) [Pubmed]
  18. Consensus statement: cardiovascular safety profile of triptans (5-HT agonists) in the acute treatment of migraine. Dodick, D., Lipton, R.B., Martin, V., Papademetriou, V., Rosamond, W., MaassenVanDenBrink, A., Loutfi, H., Welch, K.M., Goadsby, P.J., Hahn, S., Hutchinson, S., Matchar, D., Silberstein, S., Smith, T.R., Purdy, R.A., Saiers, J. Headache. (2004) [Pubmed]
  19. Glucose tolerance test and glycosylated haemoglobin measurement for diagnosis of diabetes mellitus--an assessment of the criteria of the WHO Expert Committee on Diabetes Mellitus 1980. Albutt, E.C., Nattrass, M., Northam, B.E. Ann. Clin. Biochem. (1985) [Pubmed]
  20. NTP-CERHR Expert Panel Update on the Reproductive and Developmental Toxicity of di(2-ethylhexyl) phthalate. Kavlock, R., Barr, D., Boekelheide, K., Breslin, W., Breysse, P., Chapin, R., Gaido, K., Hodgson, E., Marcus, M., Shea, K., Williams, P. Reprod. Toxicol. (2006) [Pubmed]
  21. Immunological research in clinical psychiatry: report on the consensus debate during the 7th Expert Meeting on Psychiatry and Immunology. Arolt, V., Rothermundt, M., Peters, M., Leonard, B. Mol. Psychiatry (2002) [Pubmed]
  22. A classification of atrial flutter and regular atrial tachycardia according to electrophysiological mechanisms and anatomical bases; a Statement from a Joint Expert Group from The Working Group of Arrhythmias of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Saoudi, N., Cosío, F., Waldo, A., Chen, S.A., Iesaka, Y., Lesh, M., Saksena, S., Salerno, J., Schoels, W. Eur. Heart J. (2001) [Pubmed]
  23. Critical evaluation of adult treatment panel III criteria in identifying insulin resistance with dyslipidemia. Liao, Y., Kwon, S., Shaughnessy, S., Wallace, P., Hutto, A., Jenkins, A.J., Klein, R.L., Garvey, W.T. Diabetes Care (2004) [Pubmed]
  24. The role of pharmacologic treatment guidelines for bipolar disorder. Perlis, R.H. The Journal of clinical psychiatry. (2005) [Pubmed]
  25. Reassessment of the association between Guillain-Barré syndrome and receipt of swine influenza vaccine in 1976-1977: results of a two-state study. Expert Neurology Group. Safranek, T.J., Lawrence, D.N., Kurland, L.T., Culver, D.H., Wiederholt, W.C., Hayner, N.S., Osterholm, M.T., O'Brien, P., Hughes, J.M. Am. J. Epidemiol. (1991) [Pubmed]
  26. American College of Cardiology/American Heart Association Expert Consensus Document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. O'Rourke, R.A., Brundage, B.H., Froelicher, V.F., Greenland, P., Grundy, S.M., Hachamovitch, R., Pohost, G.M., Shaw, L.J., Weintraub, W.S., Winters, W.L. J. Am. Coll. Cardiol. (2000) [Pubmed]
  27. Evaluation of an expert system on lymph node pathology. Nathwani, B.N., Clarke, K., Lincoln, T., Berard, C., Taylor, C., Ng, K.C., Patil, R., Pike, M.C., Azen, S.P. Hum. Pathol. (1997) [Pubmed]
  28. Heterogeneous effect of an Emergency Department Expert Charting System. Buller-Close, K., Schriger, D.L., Baraff, L.J. Annals of emergency medicine. (2003) [Pubmed]
  29. IL-12 enhances the generation of tumour antigen-specific Th1 CD4 T cells during ex vivo expansion. Knutson, K.L., Disis, M.L. Clin. Exp. Immunol. (2004) [Pubmed]
  30. Effect of handrim diameter on manual wheelchair propulsion: mechanical energy and power flow analysis. Guo, L.Y., Su, F.C., An, K.N. Clinical biomechanics (Bristol, Avon) (2006) [Pubmed]
  31. A critique of the report of the National Institutes of Health Expert Panel on detection, evaluation, and treatment of high blood cholesterol. Olson, R.E. Arch. Intern. Med. (1989) [Pubmed]
  32. Integrating complementary medicine into cardiovascular medicine. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (Writing Committee to Develop an Expert Consensus Document on Complementary and Integrative Medicine). Vogel, J.H., Bolling, S.F., Costello, R.B., Guarneri, E.M., Krucoff, M.W., Longhurst, J.C., Olshansky, B., Pelletier, K.R., Tracy, C.M., Vogel, R.A., Vogel, R.A., Abrams, J., Anderson, J.L., Bates, E.R., Brodie, B.R., Grines, C.L., Danias, P.G., Gregoratos, G., Hlatky, M.A., Hochman, J.S., Kaul, S., Lichtenberg, R.C., Lindner, J.R., O'Rourke, R.A., Pohost, G.M., Schofield, R.S., Shubrooks, S.J., Tracy, C.M., Winters, W.L. J. Am. Coll. Cardiol. (2005) [Pubmed]
  33. Utility of the VITEK 2 Advanced Expert System for identification of extended-spectrum beta-lactamase production in Enterobacter spp. Schwaber, M.J., Navon-Venezia, S., Chmelnitsky, I., Leavitt, A., Schwartz, D., Carmeli, Y. J. Clin. Microbiol. (2006) [Pubmed]
  34. Scientific challenges for the quality control and production of group C meningococcal conjugate vaccines. Jódar, L., Griffiths, E., Feavers, I. Vaccine (2004) [Pubmed]
  35. Propylhexdrine. Wesson, D.R. Drug and alcohol dependence. (1986) [Pubmed]
  36. The international standard for plasminogen activator inhibitor-1 (PAI-1) activity. Gaffney, P.J., Edgell, T.A. Thromb. Haemost. (1996) [Pubmed]
  37. A collaborative study to establish the 2nd international standard for tissue plasminogen activator (t-PA). Gaffney, P.J., Curtis, A.D. Thromb. Haemost. (1987) [Pubmed]
  38. The first international standard for serum amyloid A protein (SAA). Evaluation in an international collaborative study. Poole, S., Walker, D., Gaines Das, R.E., Gallimore, J.R., Pepys, M.B. J. Immunol. Methods (1998) [Pubmed]
  39. SARS revisited: managing "outbreaks" with "communications". Menon, K.U. Ann. Acad. Med. Singap. (2006) [Pubmed]
  40. Lefunomide in combination therapy. Kalden, J.R., Smolen, J.S., Emery, P., van Riel, P.L., Dougados, M., Strand, C.V., Breedveld, F.C. The Journal of rheumatology. Supplement. (2004) [Pubmed]
  41. Effect of frequency of prenatal care visits on perinatal outcome among low-risk women. A randomized controlled trial. McDuffie, R.S., Beck, A., Bischoff, K., Cross, J., Orleans, M. JAMA (1996) [Pubmed]
  42. ACC Expert Consensus document on coronary artery stents. Document of the American College of Cardiology. Holmes, D.R., Hirshfeld, J., Faxon, D., Vlietstra, R.E., Jacobs, A., King, S.B. J. Am. Coll. Cardiol. (1998) [Pubmed]
  43. Evaluation of guidelines for initiation of highly active antiretroviral therapy in a longitudinal cohort of HIV-infected individuals. Ioannidis, J.P., O'Brien, T.R., Goedert, J.J. AIDS (1998) [Pubmed]
  44. American College of Cardiology/Society for Cardiac Angiography and Interventions Clinical Expert Consensus Document on cardiac catheterization laboratory standards. A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. Bashore, T.M., Bates, E.R., Berger, P.B., Clark, D.A., Cusma, J.T., Dehmer, G.J., Kern, M.J., Laskey, W.K., O'Laughlin, M.P., Oesterle, S., Popma, J.J., O'Rourke, R.A., Abrams, J., Bates, E.R., Brodie, B.R., Douglas, P.S., Gregoratos, G., Hlatky, M.A., Hochman, J.S., Kaul, S., Tracy, C.M., Waters, D.D., Winters, W.L. J. Am. Coll. Cardiol. (2001) [Pubmed]
  45. Categorizing asthma severity. Colice, G.L., Burgt, J.V., Song, J., Stampone, P., Thompson, P.J. Am. J. Respir. Crit. Care Med. (1999) [Pubmed]
 
WikiGenes - Universities